Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Frelinger

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Circulation. Cardiovascular Interventions|August 26, 2010
The Platelet Activity After Clopidogrel Termination (PACT) studyAndrew L Frelinger, Marc R Barnard, Marsha L Fox, et al.
Journal of Thrombosis and Haemostasis : JTH|December 28, 2020
Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiencyStacy E Croteau, Andrew L Frelinger, Anja J Gerrits, et al.
Current Protocols|June 25, 2021
Immunophenotypic Analysis of Platelets by Flow CytometryBenjamin E J Spurgeon, Matthew D Linden, Alan D Michelson, et al.
Platelets|May 10, 2021
Platelet count and disease - editorial policyPaul Harrison, Marie Lordkipanidzé, Andrew L Frelinger, et al.
Seminars in Thrombosis and Hemostasis|June 18, 2024
Platelet Pathophysiology: Unexpected New Research DirectionsAlan D Michelson, Andrew L Frelinger Iii, Robin L Haynes, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2022
Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders: Communication from the ISTH SSC Subcommittee on Platelet PhysiologyDiego Mezzano, Paul Harrison, Andrew L Frelinger, et al.
Thrombosis and Haemostasis|April 17, 2015
A review of platelet secretion assays for the diagnosis of inherited platelet secretion disordersAndrew D Mumford, Andrew L Frelinger, Christian Gachet, et al.
Research and Practice in Thrombosis and Haemostasis|October 29, 2025
A minimum valency of 4 is required for robust activation of platelets in flow cytometry by multivalent nanobodies to Glycoprotein VI, C-type lectin-like receptor 2 and Platelet Endothelial Aggregation Receptor 1Rachel E Lamerton, Eleyna M Martin, Jacqueline Perry, et al.
Seminars in Thrombosis and Hemostasis|October 22, 2004
Application of flow cytometry to platelet disordersMatthew D Linden, Andrew L Frelinger, Marc R Barnard, et al.
Journal of the American College of Cardiology|June 15, 2004
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerizationMark I Furman, Lori A Krueger, Matthew D Linden, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Circulation. Cardiovascular Interventions|August 26, 2010
The Platelet Activity After Clopidogrel Termination (PACT) studyAndrew L Frelinger, Marc R Barnard, Marsha L Fox, et al.
Journal of Thrombosis and Haemostasis : JTH|December 28, 2020
Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiencyStacy E Croteau, Andrew L Frelinger, Anja J Gerrits, et al.
Current Protocols|June 25, 2021
Immunophenotypic Analysis of Platelets by Flow CytometryBenjamin E J Spurgeon, Matthew D Linden, Alan D Michelson, et al.
Platelets|May 10, 2021
Platelet count and disease - editorial policyPaul Harrison, Marie Lordkipanidzé, Andrew L Frelinger, et al.
Seminars in Thrombosis and Hemostasis|June 18, 2024
Platelet Pathophysiology: Unexpected New Research DirectionsAlan D Michelson, Andrew L Frelinger Iii, Robin L Haynes, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2022
Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders: Communication from the ISTH SSC Subcommittee on Platelet PhysiologyDiego Mezzano, Paul Harrison, Andrew L Frelinger, et al.
Thrombosis and Haemostasis|April 17, 2015
A review of platelet secretion assays for the diagnosis of inherited platelet secretion disordersAndrew D Mumford, Andrew L Frelinger, Christian Gachet, et al.
Research and Practice in Thrombosis and Haemostasis|October 29, 2025
A minimum valency of 4 is required for robust activation of platelets in flow cytometry by multivalent nanobodies to Glycoprotein VI, C-type lectin-like receptor 2 and Platelet Endothelial Aggregation Receptor 1Rachel E Lamerton, Eleyna M Martin, Jacqueline Perry, et al.
Seminars in Thrombosis and Hemostasis|October 22, 2004
Application of flow cytometry to platelet disordersMatthew D Linden, Andrew L Frelinger, Marc R Barnard, et al.
Journal of the American College of Cardiology|June 15, 2004
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerizationMark I Furman, Lori A Krueger, Matthew D Linden, et al.
Pageof 10